Literature DB >> 1155056

Treatment of acute maxillary sinusitis. IV. Ampicillin, cephradine and erythromycinestolate with and without irrigation.

A Axelsson, N Grebelius, C Jensen, O Melin, F Singer.   

Abstract

Six groups, each containing 50 patients with acute maxillary sinusitis, were treated with ampicillin plus nasal decongestant, ampicillin plus irrigation, cephradine plus nasal decongestant, cephradine plus irrigation, erythromycinestolate plus nasal decongestant, erythromycinestolate plus irrigation. The diagnosis was radiologically established and the healing likewise radiologically assessed on the fifth, tenth and fifteenth day. Treatment was given for 10 days. All groups demonstrated a similar radiological healing except cephradine plus nasal decongestant which was inferior to the others. Contrarily, side effects were least frequent in the cephradine groups and most frequent in patients cured with ampicillin. The difficulty in choosing the best treatment is discussed in relation to such factors as therapeutic results, side effects, long-term consequences of antibiotic treatment, establishment of any bacterial etiology and penetration characteristics of antibiotics into the diseased sinus.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1155056     DOI: 10.3109/00016487509124713

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  3 in total

Review 1.  Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines.

Authors:  Eli O Meltzer; Daniel L Hamilos
Journal:  Mayo Clin Proc       Date:  2011-04-13       Impact factor: 7.616

Review 2.  Nasal saline irrigations for the symptoms of acute and chronic rhinosinusitis.

Authors:  Nils Achilles; Ralph Mösges
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

3.  How patients experience antral irrigation.

Authors:  Karin Blomgren; Lotta Eliander; Maija Hytönen; Suvi Ylinen; Mirja Laitio; Paula Virkkula
Journal:  Clin Med Insights Ear Nose Throat       Date:  2015-05-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.